EGR1 has been reported to act as a tumour suppressor in several cancers30–32, however, in prostate cancer, EGR1 has been proposed to be an oncogene33,34, which may suggest a tissue specific biological function. This evidence concerns the gene EGR1 and prostate carcinoma.